The program shall collect the following data for the Director and the Oversight Committee:

(1) Information on the number of participants served and the number of needles and syringes distributed;

(2) A demographic profile of the participants served, including but not limited to: age, sex, ethnicity, area of residence, types of drugs used, length of drug use, and frequency of injection;

(3) The number of participants entering drug counseling and treatment, and the number of referrals made by the program for drug counseling and treatment;

(4) Data on participants regarding HIV testing and other communicable disease testing, counseling, or other social services;

(5) Assessment of the impact of the program on needle and syringe sharing and other high risk behaviors;

(6) Impact on the transmission of HIV and hepatitis infection among injection drug users and their contacts;

(7) Other data as requested by the Director or Oversight Committee to assess the cost effectiveness and strengths and weaknesses of the program.

75 Del. Laws, c. 428, § ?1; 78 Del. Laws, c. 86, § ?1; 80 Del. Laws, c. 398, § ?1;